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ABSTRACT 
Controlled drug delivery systems significantly enhances therapeutic efficacy of drugs. Drug retarding polymers are the key performers in such 
designed systems.  
Objective: The main objective of study is to evaluate antidiabetic effect of gliclazide loaded pellets developed by green synthesis technique where in 
gum Kondagogu is used as natural drug retarding polymer and compared with existing Gliclazide Marketed formulation.  
 Methods: The study is carried out in Wistar rats with body weight ranging between 100-220g. Diabetes was induced in animals by injecting alloxan 
150mg/kg/bodyweight intraperitoneally (i.p.). Animals were divided into four groups. Group I - Control, Group II- Diabetic Control, Group III- Diabetic 
treated with Gliclazide Marketed formulation, and Group IV- Diabetic treated with gliclazide loaded pellets orally. Fasting blood glucose levels were 
estimated at 0, 2, 4, 6, 8, 10, 12 and 24 hours to understand the release of the drug from polymer matrix.  
Results: The results have shown that the on single oral administration of gliclazide loaded pellets coated with gum Kondagogu showed almost similar anti-
diabetic activity when compared with marketed formulation  The maximum reduction  in the glucose level were observed at 4th and 6th hour and later the 
glucose levels were sustained in the same pattern to that of marketed formulation.  
Conclusion: In the present study, an effort has been made to evaluate the efficacy of gum kondagogu as a novel controlled release matrix forming 
material and thus it could be concluded that gum kondagogu could be a controlled release matrix polymer and be a suitable substituent to existing 
synthetic polymers for drug retardation in the pharmaceutical industry. 
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INTRODUCTION 
Diabetes mellitus (DM) is common endocrine disorder affecting 
more than 200 million people Worldwide. [1] It is a metabolic 
disorder characterized by hyperglycaemia, hypertriglyceridaemia 
and hypercholesterolaemia resulting from defects in insulin 
secretion or action or both [2]. Gliclazide is a second generation 
hypoglycaemic drug belongs to the sulfonylurea class of insulin 
secretagognes mainly used in the treatment of non insulin 
dependent diabetes mellitus (NIDDM). Gliclazide reduces blood 
glucose levels in patients suffering NIDDM by correcting both 
defecting insulin secretion and peripheral resistance [3]. Controlled 
drug delivery systems significantly enhances therapeutic efficacy of 
drugs. Drug release retarding polymers are the key performers in 
such designed systems. A wide range of polymers like natural, semi-
synthetic and synthetic from various origins are investigated as drug 
retarding polymeric materials. The most common and effective 
synthetic polymers in combination used for sustained 
release/controlled release are ethyl cellulose, hydroxypropyl 
methylcellulose and eudragits [4, 5]. Recent investigation reveals 
that application of new natural hydrophilic polymers as drug 
carriers have received considerable attention because they are 
readily availability, safe, cost-effective, biocompatible, biodegradable 
and ecofriendly. Some natural gums such as xanthan gum, guar gum, 
gum karaya, olibanum resin, chitosan, gum copal and gum damar 
were used in controlled drug delivery systems but found to be 
unable to sustain the drug release for a longer time(>8hr), even at a 
higher concentration. Therefore the study of new natural polymers 
for retarding drug release alone and not in combination at a lower 
concentration is the motive of research and the other hand to 
compare the drug retarding property with respect to existing 
marketed formulation mostly composed of synthetic polymers. [6,7]. 
The natural drug retarding polymer selected for the study is Gum 
Kondagogu (GK). GK is a tree exudates gum obtained from the bark 
Cochlospermum gossypium (DC) belonging to family Bixaceae. The 
biopolymer GK backbone is a polysaccharide composed of α-D- 
GalpA-(1→4)-α-L-Rhap. GK is classified under 
rhamnogalactouronans type of gums and rich in galactose, rhamnose 
and uronic acids [8]. The past research acknowledged the use of gum 
kondagogu in combination with other natural and semi-synthetic 
polymers [9, 10] as a drug retarding polymeric material.   
In the present study, an effort has been made to evaluate the efficacy 
of gum kondagogu as a novel controlled release matrix forming 
material and gum ghatti is used as a binder in the formulation. 
MATERIALS AND METHODS 
Chemicals and Reagents 
Gliclazide was purchased from Indus Laboratories, Hyderabad. 
Grade I Gum Kondagogu and Grade –I Gum Ghatti were procured 
from Girijan Co-Operative Corporation (GCC), Hyderabad, Alloxan 
monohydrate and all other analytical reagents were obtained from 
SD. Fine Chemicals. 
Experimental Animals 
 Healthy, 6-8 week old Albino Wistar rats with body weight ranging 
between          100-220g were obtained from Albino Research 
Institute, Hyderabad, India were used in the investigation.  The rats 
were allocated into four groups with approximately same mean 
body weights. Each animal were assigned a unique animal 
identification number which was tattooed in the ear. The animals 
were housed individually in plastic cages with sterilized sawdust. All 
animals were housed in single air conditioned room with 12hr 
light/dark cycles, and temperature was maintained at 27ºC ± 2º C 
with a relative humidity of 60±5%. From the arrival of the rats until 
the end of the experiment period, animal diet and water were 
provided ad lib. Experimental animals were acclimatization for 
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2weeks before the start of the study. This study was conducted in 
accordance with Good Laboratory Practice and OECD -407 
(Organization for Economic Cooperation and Development) 
guidelines and regulations. In addition, the study protocol and the 
use of experimental animals were reviewed and approved by the 
Institutional Animal Ethical Committee (25/50/2013/CPCSEA).   
Experimental Design 
Marketed formulation containing gliclazide and gliclazide loaded pellets 
coated with GK (drug retarding material) were suspended in about 2ml 
of water and were administered to animals orally by gavages. Animals 
were fasted they were deprived from food but not water for 12hr were 
used to assess the effect of Marketed tablets containing gliclazide and 
gliclazide loaded pellets [11]. 
Comparative anti-diabetic activity with marketed gliclazide tablets 
and with gliclazide loaded pellets (GK as drug retarding material) 
in Wistar Albino rats 
Preparation of gliclazide loaded pellets 
Pellets were synthesized by green technology. Gliclazide was coated 
with Gum Kondagogu as a drug retarding material and Gum Ghatti was 
added as binder. The mixture containing 10% gums was added slowly 
in the form of mucilage (20% w/v) and mixed uniformly and subjected 
to centrifugal force in a coating pan. A required gum solution as a 
binder is added to the pellets formed until a required coating is 
achieved. The obtained pellets are subjected to sieving #18/20 followed 
by #20/25. The obtained pellets were dried at 60º C for 12hrs in a 
convention oven and the dried pellets were stored in the air tight 
containers.  
Selection of the Dose 
The dose was selected using Animal equivalent dose (AED) calculation 
for gliclazide. The test and the reference formulation equivalent to 
600mg/kg/bodyweight were administered as a single dose by gavage. 
Based on the respective body weight doses were administered. Food 
was withheld for 2-3 hr after the administration of dose [12]. 
Absolute Human dose = 60mg/70kg= 0.857  
AED= Human Dose in mg/kg 
(Animal weight in kg/human weight in kg)0.33 
Anti-diabetic activity  
Healthy adult Albino Wistar male and female rats weighing 150-200g 
procured from Albino Research Institute, Hyderabad were used for the 
study. Diabetes was induced in animals by injecting alloxan 
150mg/kg/bodyweight intraperitoneally (i.p.) freshly prepared in 
normal saline. The animals were tested for evidence of diabetes by 
estimating their glucose levels using glucometer Pulsatum; (Pulsatum 
Health Care private Ltd).The animals were divided into four groups. 
Each group consisted of 6 animals (3M, 3F). Group I - Control, Group II- 
Diabetic Control, Group III- Diabetic treated with Marketed gliclazide 
formulation, and Group IV- Diabetic treated with gliclazide loaded 
pellets orally. Blood samples from the rats were collected from the retro 
orbital plexus puncture method. Blood glucose level was estimated at 0, 
2, 4, 6, 8, 10, 12 and 24 hours to understand the release of the drug from 
polymer matrix [13-16].  
Statistical analysis 
The data obtained in present investigation was subjected to 
statistical analysis. All results are expressed as Mean ± SD. The data 
was analyzed using Analysis of variance (ANOVA) and the group 
means were compared by Dunnet test. Values were considered 
statistically significant when p<0.05.Graph Pad Instat was used for 
the analysis of data. 
RESULTS  
Evaluation of In Vivo- anti-diabetic study  
There is an increase demand for controlled drug delivery system 
designed using natural polysaccharides as a retarding material. In the 
present investigation grade I gum Kondagogu and Grade I gum Ghatti 
were used and shown in Fig. 1&2 respectively. Diabetes induced by 
Alloxan was treated by gliclazide which is a potent hypoglycemic drug 
used in the treatment of NIDDM. The anti-diabetic drug gliclazide 
loaded pellets coated with gum kondagogu was compared with 
marketed extended release gliclazide formulation. The results shown in 
Fig. 3 indicates that on single oral administration of gliclazide loaded 
pellets coated with gum Kondagogu showed almost similar anti-
diabetic activity to that of marketed formulation. The maximum 
reduction  in the glucose level were observed at 4th and 6th hour and 
later the glucose levels were sustained in the same manner similar to 
that of marketed formulation. 
 
Figure 1: Specimen of grade I Gum Kondagogu 
                  
Figure 2: Specimen of Grade I Gum Ghatti 
    
 
Figure 3: Anti-diabetic activity of gliclazide loaded pellets in 
comparison to marketed formulation in alloxan induced 
diabetic rats (n=6) 
DISCUSSION 
In order to have a better comparison between synthetic polymers and 
natural polymers, gliclazide was chosen as model drug and antidiabetic 
activity was evaluated. The evaluation was based on the sequence of 
drug release from the drug retarding matrices and ability to reduce the 
blood glucose levels. The experimental data shows increased plasma 
concentrations of glucose higher than 250mg/dl in alloxan treated 
albino Wistar rats which has been considered as severe diabetes. The 
present study revealed that the gliclazide loaded pellets (GK has a 
natural drug retarding material) had marked hypoglycemic effect in 
alloxan-induced diabetes. The maximum effect was observed in 4th and 
6th hour and blood glucose levels were sustained till 24th hour similar to 
that of marketed formulation indicating alone gum kondagogu at a low 
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concentration is a potential natural drug retarding polymer which will 
be a suitable substitute for existing synthetic polymers in 
pharmaceutical industry. 
CONCLUSION 
The present study involves comparison anti-diabetic activity of 
marketed formulation usually composed of synthetic polymers and 
gliclazide loaded pellets which are formulated using gum Kondagogu 
as natural drug retarding material on alloxan induced diabetic 
Albino Wistar rats. The in vivo studies conforms reduction in the 
blood glucose level in the marketed and developed formulation 
showed similar data in control to diabetic induced animals. This 
further confirms that gum Kondagogu has an excellent drug 
retarding property and a potential controlled release excipient for 
pharmaceutical industry. 
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